跳至主要内容
临床试验/NL-OMON51498
NL-OMON51498已完成3 期

Evaluation of adhesions formation using conventional third generation endometrial ablation with and without postoperative application of an intrauterine adhesion barrier film - CLEA

Catharina-ziekenhuis0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1.Patient with refractory heavy menstrual bleeding scheduled for endometrial
  • ablation with NovaSure system
  • 2.Women 30 years old or older;
  • 3.Subjects who are willing to provide a written informed consent as approved by
  • the applicable Ethics Committee / IRB prior to participating in this clinical
  • investigation.
  • 4.Subjects who can comply with the study follow-up and other study
  • requirements.

排除标准

  • 1. Cavity length <4 or >8
  • 2. Perforation during the ablation procedure
  • 3. Previous adhesiolysis procedure or diagnosis of Asherman's disease.
  • 4. An abnormal uterine cavity at the time of ablation according to ESHRE
  • classification I to V, such as unicornis, bicornis, septate, duplex
  • 5. Medical history of cervical or endometrial cancer
  • 6. Active pelvic infection or medical history of pelvic peritonitis
  • 7. An intrauterine device in situ
  • 8. Known contraindication or hypersensitivity to PEO or PLA
  • 9. Current participation in another clinical investigation that has not yet
  • received the primary endpoint
  • 10. Any other condition that makes participation in the study contrary to the
  • patient*s best interests.

研究者

相似试验